Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Fresenius Medical Care AG & Co. KGaA is a Germany-based kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.

  • Revenue in USD (TTM)20.93bn
  • Net income in USD644.93m
  • Incorporated2006
  • Employees125.23k
  • Location
    Fresenius Medical Care AG & Co KGaAElse-Kroener-Strasse 1BAD HOMBURG VOR DER HOHE 61352GermanyDEU
  • Phone+49 61726090
  • Fax+49 61 726092301
  • Websitehttps://www.freseniusmedicalcare.com/
More ▼

Institutional shareholders

5.92%Per cent of shares held by top holders
HolderShares% Held
Pzena Investment Management LLCas of 31 Mar 202320.03m3.41%
Fiduciary Management, Inc.as of 31 Mar 20235.17m0.88%
Dodge & Coxas of 31 Mar 20234.22m0.72%
Invesco Capital Management LLCas of 31 Mar 20231.33m0.23%
Parametric Portfolio Associates LLCas of 31 Mar 2023954.58k0.16%
Balyasny Asset Management LPas of 31 Mar 2023750.61k0.13%
Arrowstreet Capital LPas of 31 Mar 2023713.62k0.12%
Jane Street Capital LLCas of 31 Mar 2023607.57k0.10%
Aperio Group LLCas of 31 Mar 2023485.56k0.08%
Goldman Sachs Asset Management LPas of 31 Mar 2023463.96k0.08%
More ▼
Data from 31 Mar 2023 - 31 Mar 2023Source: FactSet Research Systems Inc.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.